Renaissance Technologies LLC Grows Holdings in Enfusion, Inc. (NYSE:ENFN)

Renaissance Technologies LLC raised its position in Enfusion, Inc. (NYSE:ENFN - Free Report) by 167.6% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 97,100 shares of the company's stock after buying an additional 60,811 shares during the quarter. Renaissance Technologies LLC owned about 0.08% of Enfusion worth $827,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. California State Teachers Retirement System increased its stake in Enfusion by 11.0% in the 1st quarter. California State Teachers Retirement System now owns 36,002 shares of the company's stock valued at $333,000 after buying an additional 3,556 shares during the period. Allspring Global Investments Holdings LLC acquired a new position in Enfusion in the 1st quarter valued at $44,000. American Century Companies Inc. increased its stake in Enfusion by 17.1% in the 2nd quarter. American Century Companies Inc. now owns 35,897 shares of the company's stock valued at $306,000 after buying an additional 5,253 shares during the period. Principal Financial Group Inc. grew its stake in shares of Enfusion by 15.6% during the 2nd quarter. Principal Financial Group Inc. now owns 56,524 shares of the company's stock worth $482,000 after purchasing an additional 7,611 shares during the period. Finally, RiverPark Advisors LLC acquired a new position in shares of Enfusion during the 2nd quarter worth $68,000. 81.05% of the stock is owned by institutional investors and hedge funds.

Enfusion Trading Down 0.7 %

Shares of NYSE:ENFN traded down $0.06 on Tuesday, reaching $8.89. 286,917 shares of the company were exchanged, compared to its average volume of 376,809. Enfusion, Inc. has a 1-year low of $7.52 and a 1-year high of $10.45. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of 294.00, a price-to-earnings-growth ratio of 2.63 and a beta of 0.92. The company has a 50-day moving average of $8.52 and a 200-day moving average of $8.89.

Enfusion (NYSE:ENFN - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.03 by ($0.01). Enfusion had a return on equity of 6.17% and a net margin of 1.98%. The company had revenue of $49.46 million for the quarter, compared to analyst estimates of $50.27 million. As a group, analysts forecast that Enfusion, Inc. will post 0.07 earnings per share for the current year.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.